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Abstract
Background: The most common cause of hypopituitarism is pituitary adenoma. However, in the case of suprasellar
masses different etiologies are possible. We report an unusual case of primary suprasellar lymphoma presented
with hypopituitarism.
Case presentation: A 26 year old woman presented with amenorrhea, galactorrhea and neurological disorders.
Also, the laboratory work-up revealed partial hypopituitarism. The magnetic resonance imaging of the head
showed a suprasellar mass. A presumptive diagnosis of granulomatous processes was made and the patient was
given steroid therapy. Repeated brain MRI detected new lesions in the brain with regression of the suprasellar
mass. Stereotactic biopsy of the paraventricular lesion revealed the diagnosis of B-cell lymphoma.
Conclusion: This case presentation reports a rare cause of hypopituitarism. Primary suprasellar lymphoma is
extremely rare and represented a real diagnostic challenge. Besides, suprasellar masses are varied in aetiology and
can present diagnostic problems for a radiologist. Also, because of the increased incidence of PCNSL, lymphoma
must be kept in mind in the differential diagnosis of lesions in the suprasellar region.
Background
The suprasellar region is an anatomically complex area
where a number of neoplastic, infectious, inflammatory,
developmental and vascular pathologies can occur. The
most common etiology of hypopituitarism is the pitui-
tary adenoma, accounting for 10 to 15% of intracranial
neoplasms [1]. Differentiation among various etiologies
may not always be easy, since many of these lesions may
mimic the clinical, endocrinologic and radiologic pre-
sentations of pituitary adenomas. The diagnosis of
suprasellar lesions involves a multidisciplinary effort.
We report an unusual case of primary suprasellar lym-
phoma presenting as hypopituitarism.
Case presentation
A 26 year-old-woman, with a history of infertility for five
years (treated by ovulation induction medications), was
admitted to the hospital for evaluation of amenorrhea,
galactorrhea and neurological disorders. She was well
until 6 months before her admission in the neurology
department of the University Hospital of Rabat. She
developed weakness, headaches associated with nausea
and vomiting, shaking chills, night sweats, an 8-pound
weight loss and diplopia. Computed tomography scan
(CT scan) of the brain showed a hyperdense mass in the
suprasellar region (Figure 1). Magnetic resonance ima-
g i n g( M R I )o ft h eb r a i n( T 1a n dT 2w e i g h t e dw i t hc o n -
trast) revealed an enhancing suprasellar mass (9 × 6 mm)
and thickening of pituitary stalk (Figure 2).
Laboratory findings showed: microcytic anemia (10 g/dl),
hyponatremia (130 mEq/L), elevated erythrocyte sedimen-
tation rate (40 mm in first hour) with an increased
alpha-2-gobulin in serum protein electrophoresis. An
endocrinological evaluation revealed low levels of follicle
stimulating hormone (2.5 IU/L; normal ranges in the
laboratory 5-20 IU/L) and luteinizing hormone (0.5 IU/L;
normal ranges in the laboratory 10-70 IU/L), serum prolac-
tin level was greatly increased (145 ng/ml; normal ranges in
the laboratory 2.8-29.2 ng/ml) without dysfunctions of
Antidiuretic Hormone. She underwent an extensive biolo-
gical work-up evaluation including: thyroid function tests,
skin testing for tuberculosis; serological tests for HIV,
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gland biopsy; all were unrevealing. Chest x-ray and abdom-
inal echography were normal.
Initially, the diagnosis of granulomatous processes was
suggested, on the basis of the patient’sp r e s e n t a t i o na n d
imaging findings. Then the patient was given predniso-
lone 60 mg/day with clinical improvement. However,
subsequent head MRI detected new lesions of the brain
in contrast with regression of the first mass (Figure 3).
She underwent stereotactic biopsy of the paraventricular
lesion. Histological examination revealed infiltrative
large-sized lymphocytes with occasional mitotic figures.
The immunohistochemical tests confirmed the diagnosis
of large B-cell lymphoma (the B-cell marker CD20 was
positive and the CD3 T-cell marker was negative)
(Figure 4). CT scan of the chest, abdomen, and pelvis
were negative.
The patient died of hydrocephalus before the initiation
of treatment two weeks after the diagnosis.
Discussion
We described an unusual presentation of brain lym-
phoma revealed by hypopituitarism. Our patient pre-
sented a partial hypopituitarism with a suprasellar mass
in brain MRI. Pituitary adenoma is the most common
cause of hypopituitarism [1]. Suprasellar masses are var-
ied in aetiology; craniopharyngioma, Rathke cleft cyst,
germ cell tumour and granulomatous processes are
others common differential diagnosis [1]. However,
Figure 1 CT scan of the brain with contrast showing the
suprasellar lesion.
A                                                        B 
             
Figure 2 MRI of the brain coronal (A) and sagittal (B) T1-
weighted images with contrast enhancement, performed at
the first presentation showing the suprasellar mass(1) with
thickening of pituitary stalk (2).
A                                                                             B 
Figure 3 Four months later after steroid treatment, MRI of the
brain showing new process developed in the CNS.
           
A  B 
C  D 
Figure 4 The histological examination confirmed the diagnosis
of pituitary lymphoma. Figures A and B shows infiltrative large-
sized lymphocytes with occasional mitotic. The immunohistocemical
tests were positive for the B-cell CD20 marker (C) and negative for
the T-cell marker CD3 (D).
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rare and represents a diagnostic challenge. Besides,
suprasellar masses can present diagnostic problems for a
radiologist. MRI findings for pituitary adenomas with
suprasellar extension typically have a “figure of eight” or
“snowman” appearance and are strongly enhanced. Cra-
niopharyngioma have a heterogeneous appearance with
solid and cystic elements tumour in the suprasellar
region. Rathke cleft cysts usually have the following ima-
ging features: a sellar epicentre, smooth contour, lack of
calcification, lack of internal enhancement, and a homo-
geneous signal intensity within the lesion. The character-
istic features of granulomatous diseases are thickening of
the pituitary stalk and absence of a normal, bright poster-
ior pituitary signal. Imaging of germ cell tumour shows
generally an infiltrative, solid, homogeneous mass in the
midline with intense contrast enhancement [1]. Never-
theless, there are no significant distinctive radiologic
characteristics of suprasellar lymphoma. More often, the
MRI findings in primary CNS lymphoma are mass lesions
that are iso- to hypointense on T1- and T2-weighted
images and tend to have strong homogenous enhance-
ment following contrast administration in immunocom-
potent patients, as in the present cases [1]. The absence
of T2 prolongation results from the dense cellularity and
high nucleus-to-cytoplasm ratio of lymphoma, and it may
help in the differentiation of primary CNS lymphoma
from other brain tumours [1-3].
To our knowledge, only nineteen cases of primary
lymphoma involving the hypothalamic-pituitary region
have been previously reported (Table 1) [2-20]. In the
present case the diagnosis of granulomatous processes
has been made on the basis of patient presentation and
imaging findings. The treatment was subsequently
initiated with steroid therapy and showed clinical
improvement and suprasellar mass regression. Though,
subsequent head MRI detected new lesions in the cere-
bellum and periventricular region (Figure 3). Then, the
diagnosis of primary central nervous system lymphoma
(PCNSL) was strongly support according to neuroima-
ging work-up, because the vast majority of PCNS
tumors arise in the deep hemispheric periventricular
white matter, the corpus callosum, cerebellum, orbits,
and cranial nerves [21].
In the series of patients reported (Table 1), only in
one case was the presumptive diagnosis lymphoma of
the brain. In the large majority of cases presumptive
diagnosis was pituitary adenoma. Confirmation of diag-
nosis was most frequently obtained with surgery [2-20].
In our review of 20 cases of sellar and suprasellar lym-
phoma including our patient, we found that the mean
age of patients was 55.5 years (range 26 - 86 years). 60%
of the patients were male and 40% were female. By con-
trast, our patient was a 26 year-old-woman.
The most common presentation was hypopituitarism
(75%), followed by headache (55%), diplopia (40%), dia-
betes insipidus (31%) and hyperprolactinemia (25%).
Histologically, similar to PCNSL, most lymphomas of
the suprasellar region are B-cell non-Hodgkin lym-
phoma. The MRI of the head demonstrated enhancing
parasellar masses with diffuse enlargement of the pitui-
tary gland (95%), suprasellar lesion (45%), cavernous
sinus extension (35%), and stalk thickening (20%).
Indeed, the present case had hypopituitarism at presen-
tation and brain MRI shows suprasellar lesion and stalk
thickening.
Nevertheless, primary central nervous system lym-
phoma (PCNSL) represents approximately less than 2%
of primary brain tumors. Its incidence has increased
over the last 30 years [19]. So far, despite recent thera-
peutic advances, PCNSL exhibit one of the worst prog-
noses among all non-Hodgkin lymphomas (median
survival < 6 months) [22]. Our patient died two weeks
after diagnosis of hydrocephalus.
For a long time, radiotherapy (RT) has been the stan-
dard treatment, producing a response rate of 60-65%
and a notable neurological improvement in most cases
of PCNSL. However, relapse usually occurred within a
few months after RT. Although the introduction of sys-
temic chemotherapy based on CHOP (cyclophospha-
mide, doxorubicine, vincristin and prednisone) regimen
and high-dose methotrexate followed by radiation ther-
apy has consistently improved survival, the prognosis of
PCNSL still dismal, with high rates of local relapse and
consequent death. About half of the patients reported
received chemotherapy, only in three cases without cra-
nial radiation [22]. Regimens used were different and
were in the most cases extrapolated from the protocol
used in PCNSL. Despite the increasing number of stu-
dies published since a decade on PCNSL and recent
therapeutic advances, several questions still remain
unanswered about the optimal management of these
tumors.
This case presentation reports a rare cause of hypopi-
tuitarism. Primary suprasellar lymphoma is extremely
rare and represented a real diagnostic challenge. Supra-
sellar masses are varied in aetiology and can present
diagnostic problems for a radiologist. But the differential
diagnosis can be narrowed down by taking into account
the patient’s age, clinical presentation, and imaging
appearances. Also, because of the increased incidence of
PCNSL, lymphoma must be kept in mind in the differ-
ential diagnosis of lesions in the suprasellar region.
Conclusion
This case presentation reported a rare cause of hypopi-
tuitarism. Suprasellar region may be affected by a wide
variety of tumors. Nevertheless, primary suprasellar
Fadoukhair et al. BMC Endocrine Disorders 2010, 10:19
http://www.biomedcentral.com/1472-6823/10/19
Page 3 of 5lymphoma is extremely rare and represented a real diag-
nostic challenge. This case demonstrates that lymphoma
must be kept in mind in the differential diagnosis of
lesions in the suprasellar region because of the increased
incidence of PCNSL.
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Table 1 Clinical characteristics of 20 patients with primary sellar and suprasellar lymphoma
Authors and Year (Ref) Age
Sex
Clinical Presentation Radiological findings Origin
Singh et al., 1993 [2] 28, M HA, visual loss, facial numbness CT: lesion in suprasellar, and right
parasellar region extending into the
sphenoid sinus
B-Cell
Samuels et al., 1994 [3] 49, M HA, nystagmus, decreased libido,
hypopit, DI, PRL
MRI: enhancement of a suprasellar mass
with infiltration of contiguous structures
B-Cell
Gottfredsson et al., 1996 [4] 48, M HA, nausea/vomiting, meningismus,
fever, diplopia
CT: 9 mm enhancing mass in the
pituitary region
B-Cell
Shaw et al., 1997 [5] 73, F HA, fatigue, diplopia, polyuria, hypopit,
DI, PRL
MRI: mass filling sphenoid sinus on the
right, contiguous with pituitary
B-Cell
Li et al., 1998 [6] 77, M Weakness, hypopit - B-Cell
Sakakibara et al., 1998 [7] 53, M HA, diplopia - T-Cell
Freda et al., 1999 [8] 48, M HA, diplopia MRI: mass involving suprasella, sphenoid
sinus, and cavernous sinus
B-Cell
Kuhn et al., 1999 [9] 67, F Diplopia, hypopit CT/MRI: large intrasellar, suprasellar, and
right parasellar lesion invading the right
cavernous sinus
T-Cell
Au et al., 2000 [10] 83, M HA, visual loss, hypopit, DI MRI: isointense bilobed tumor of
pituitary fossa with central hemorrhagic
area. Compressed hypothalamus and
optic chiasm
B-Cell
Mathiasen et al., 2000 [11] 65, M Weakness, decreased libido, hypopit, PRL MRI: homogenously enhancing sellar
and suprasellar mass
B-Cell
Singh et al.,
2000 [12]
44, M HA, visual loss, decreased libido MRI: enhancing mass involving sella,
and parasellar regions with infiltration of
the cavernous sinus.
B-Cell
Spina et al., 2000 [13] 52, F HA, diplopia, hypopit, DI - T-Cell
Landman et al., 2001 [14] 86, F Fever, chills, weight loss, hypopit, DI MRI: mass in pituitary fossa extending
into suprasellar cistern. Isointense on T1,
enhancing postgadolinium
B-Cell
Silfen et al., 2001 [15] 15, F Polyuria, polydipsia, weight loss, hypopit,
DI
MRI: 9 mm enhancing lesion in the
pituitary stalk
B-Cell
Kaufmann et al., 2002 [16] 74, M Visual loss, mental status change,
hypopit
MRI: sellar and suprasellar masse and
extension into the cavernous and
sphenoid sinuses
B-cell
Katz et al., 2003 [17] 64, F nausea/vomiting, diarrhea, hypopit, DI MRI: minimal enlargement of the
pituitary region
B-Cell
Huang et al., 2005 [18] 47, M Fever, chills, decreased libido, hypopit CT: homogeneous enhanced pituitary
region mass (22 × 14 mm)
T-Cell
J.K Liu et al., 2007 [19] 26, M HA, diplopia, hypopit MRI: enhancing sellar mass with
suprasellar extension compressing the
optic chiasm.
NK/T-Cell
Krypciak et al., 2010 [20] 78, F Weakness, weight loss, nystagmus,
hypopit, PRL
CT: 10 mm enhanced pituitary mass B-Cell
Present study 26, F HA, weight loss, amenorrhea, diplopia,
nystagmus, hypopit, PRL
MRI: enhancing suprasellar mass B-Cell
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